Marcela Kreslová

Marcela Kreslová


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2018 in World Journal of Gastroenterology
Verified
Journal Article
Open access
JSJosef Sýkora
Josef Sýkora
RPRenáta Pomahačová
Renáta Pomahačová
Marcela KreslováMarcela Kreslová
Marcela Kreslová
DCDominika Cvalínová
Dominika Cvalínová
Premysl StychPremysl Stych
Premysl Stych
JSJan Schwarz
Jan Schwarz
Current global trends in the incidence of pediatric-onset inflammatory bowel disease

18 October 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
Marcela KreslováMarcela Kreslová
Marcela Kreslová
OKOlga Kirchnerová
Olga Kirchnerová
DRDaniel Rajdl
Daniel Rajdl
VSVendula Sudová
Vendula Sudová
JBJiří Blažek
Jiří Blažek
Josef SýkoraJosef Sýkora
Josef Sýkora
Introduction: Asthma as a chronic inflammatory disorder has been suggested as a risk factor for endothelial dysfunction (ED), but studies on the association between asthma and cardiovascular disease (CVD) risk are limited. Background: We assessed associations of ED with the severity of asthma, eosinophilic inflammation, lung function, and asthma control. Methods: 52 young asthmatics (median age of 25.22 years) and 45 healthy individuals were included. Demographic, clinical, and laboratory findings were recorded. We evaluated microvascular responsiveness by recording the reactive hyperemia index (RHI) indicating post-occlusive peripheral endothelium-dependent changes in vascular tone using the Itamar Medical EndoPAT2000. VCAM-1, ADMA, high-sensitive CRP (hsCRP), and E-selectin were measured. Results: Asthmatics had considerably lower RHI values (p < 0.001) with a dynamic decreasing trend by asthma severity and higher hsCRP levels (p < 0.001). A substantial increase in hsCRP and E-selectin with asthma severity (p < 0.05) was also observed. We confirmed a higher body mass index (BMI) in asthmatics (p < 0.001), especially in women and in severe asthma. Conclusions: We demonstrated the progression of CVD in asthmatics and the association of the ongoing deterioration of ED with the inflammatory severity, suggesting that the increased risk of CVD in young asthmatics is dependent on disease severity. The underlying mechanisms of risk factors for CVD and disease control require further study.

17 November 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
Marcela KreslováMarcela Kreslová
Marcela Kreslová
PJPetr Jehlička
Petr Jehlička
ASAneta Sýkorová
Aneta Sýkorová
DRDaniel Rajdl
Daniel Rajdl
EKEva Klaskova
Eva Klaskova
Josef SýkoraJosef Sýkora
Josef Sýkora
Introduction: Multisystem inflammatory syndrome in children (MIS-C) is a new clinical entity that has emerged in the context of the COVID-19 pandemic. Despite the less severe course of the disease, varying degrees of cardiovascular events may occur in MIS-C; however, data on vascular changes occurring in MIS-C are still lacking. Endothelial dysfunction (ED) is thought to be one of the key risk factors contributing to MIS-C. Background: We conducted a prospective observational study. We investigated possible manifestations of cardiac and endothelial involvement in MIS-C after the treatment of the acute stage and potential predictive biomarkers in patients with MIS-C. Methods: Twenty-seven consecutive pediatric subjects (≥9 years), at least three months post-treated MIS-C of varying severity, in a stable condition, and twenty-three age- and sex-matched healthy individuals (HI), were enrolled. A combined non-invasive diagnostic approach was used to assess endothelial function as well as markers of organ damage using cardiac examination and measurement of the reactive hyperemia index (RHI), by recording the post- to pre-occlusion pulsatile volume changes and biomarkers related to ED and cardiac disease. Results: MIS-C patients exhibited a significantly lower RHI (indicative of more severe ED) than those in HI (1.32 vs. 1.80; p = 0.001). The cutoff of RHI ≤ 1.4 was independently associated with a higher cardiovascular risk. Age and biomarkers significantly correlated with RHI, while serum cystatin C (Cys C) levels were independently associated with a diminished RHI, suggesting Cys C as a surrogate marker of ED in MIS-C. Conclusions: Patients after MIS-C display evidence of ED, as shown by a diminished RHI and altered endothelial biomarkers. Cys C was identified as an independent indicator for the development of cardiovascular disease. The combination of these factors has the potential to better predict the cardiovascular consequences of MIS-C. Our study suggests that ED may be implicated in the pathophysiology of this disease.

30 October 2021 in Physiological Research
Verified
Journal Article
Closed access
Marcela KreslováMarcela Kreslová
Marcela Kreslová
ASA Sýkorová
A Sýkorová
RBR Bittenglová
R Bittenglová
JSJ Schwarz
J Schwarz
RPR Pomahačová
R Pomahačová
JSJ Sýkora
J Sýkora
There are concerns about altered vascular functions that could play an important role in the pathogenesis and influence the severity of chronic disease, however, increased cardiovascular risk in paediatric cystic fibrosis (CF) has not been yet fully understood. Aim was to analyze vascular disease risk and investigate changes over times in CF and controls. We prospectively enrolled 22 CF subjects (a median age of 16.07 years), and 22 healthy demographically matched controls (a median age of 17.28 years) and determined endothelial function. We utilized a combined diagnostic approach by measuring the plethysmographic Reactive Hyperemia Index (RHI) as the post-to preocclusive endothelium-dependent changes of vascular tone, and biomarkers that are known to be related to endothelial dysfunction (ED): asymmetric dimethyl arginine (ADMA), high-sensitive CRP (hsCRP), VCAM-1 and E-selectin. RHI values were significantly lower in CF young adults (p<0.005). HsCRP (p<0.005), E-selectin (p<0.001) and VCAM-1 (p<0.001) were significantly increased in CF patients since childhood. The findings have provided a detailed account of the ongoing process of microvascular dysfunction with gradual progression with the age of CF patients, making them further at risk of advanced vascular disease. Elevations of biomarkers in CF children with not yet demonstrated RHI changes but with significantly reduced RHI in adulthood and lipid profile changes indicate the possible occurrence of ED with CF-related specific risk factors over time and will enable us to provide the best possible support.

20 December 2022 in Pediatric Pulmonology
Verified
Journal Article
Closed access
VSVeronika Schwarzová
Veronika Schwarzová
JSJan Schwarz
Jan Schwarz
KMKatarina Mitrová
Katarina Mitrová
PDPavel Dřevínek
Pavel Dřevínek
Marcela KreslováMarcela Kreslová
Marcela Kreslová
TDTereza Doušová
Tereza Doušová

4 May 2020 in Journal of Paediatrics and Child Health
Verified
Journal Article
Closed access
PDF file
JSJan Schwarz
Jan Schwarz
JSJosef Sýkora
Josef Sýkora
RPRenáta Pomahačová
Renáta Pomahačová
ASAneta Sýkorová
Aneta Sýkorová
JFJiří Fremuth
Jiří Fremuth
Marcela KreslováMarcela Kreslová
Marcela Kreslová